ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 100 filers reported holding ADAMAS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 2.58 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $56,000 | +86.7% | 11,279 | +96.7% | 0.00% | – |
| Q2 2021 | $30,000 | +500.0% | 5,733 | +403.8% | 0.00% | – |
| Q1 2021 | $5,000 | -68.8% | 1,138 | -81.5% | 0.00% | – |
| Q2 2020 | $16,000 | -27.3% | 6,135 | -19.7% | 0.00% | – |
| Q1 2020 | $22,000 | -75.6% | 7,644 | -67.4% | 0.00% | – |
| Q4 2019 | $90,000 | +36.4% | 23,439 | +81.1% | 0.00% | – |
| Q3 2019 | $66,000 | -32.0% | 12,945 | -17.4% | 0.00% | – |
| Q2 2019 | $97,000 | -73.2% | 15,671 | -69.2% | 0.00% | – |
| Q1 2019 | $362,000 | +144.6% | 50,846 | +192.4% | 0.00% | – |
| Q4 2018 | $148,000 | -20.4% | 17,387 | +87.6% | 0.00% | – |
| Q3 2018 | $186,000 | -96.1% | 9,269 | -95.0% | 0.00% | -100.0% |
| Q2 2018 | $4,816,000 | +1626.2% | 186,415 | +1494.4% | 0.00% | – |
| Q1 2018 | $279,000 | +248.8% | 11,692 | +392.7% | 0.00% | – |
| Q4 2017 | $80,000 | -11.1% | 2,373 | -44.3% | 0.00% | – |
| Q3 2017 | $90,000 | +25.0% | 4,261 | +3.2% | 0.00% | – |
| Q2 2017 | $72,000 | +1700.0% | 4,130 | +1642.6% | 0.00% | – |
| Q1 2017 | $4,000 | -93.9% | 237 | -94.0% | 0.00% | – |
| Q4 2016 | $66,000 | +2100.0% | 3,958 | +1802.9% | 0.00% | – |
| Q3 2016 | $3,000 | -25.0% | 208 | -22.4% | 0.00% | – |
| Q2 2016 | $4,000 | +33.3% | 268 | +14.5% | 0.00% | – |
| Q1 2016 | $3,000 | -62.5% | 234 | -19.0% | 0.00% | – |
| Q4 2015 | $8,000 | +700.0% | 289 | +425.5% | 0.00% | – |
| Q3 2015 | $1,000 | -80.0% | 55 | -72.4% | 0.00% | – |
| Q2 2015 | $5,000 | +400.0% | 199 | +128.7% | 0.00% | – |
| Q1 2015 | $1,000 | -75.0% | 87 | -63.3% | 0.00% | – |
| Q4 2014 | $4,000 | +300.0% | 237 | +690.0% | 0.00% | – |
| Q3 2014 | $1,000 | 0.0% | 30 | -53.1% | 0.00% | – |
| Q2 2014 | $1,000 | – | 64 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,423,578 | $8,826,000 | 6.08% |
| Healthcare Value Capital, LLC | 200,000 | $1,240,000 | 2.33% |
| ARMISTICE CAPITAL, LLC | 2,700,000 | $16,740,000 | 1.06% |
| DELTEC ASSET MANAGEMENT LLC | 550,836 | $3,415,000 | 0.75% |
| Broadfin Capital, LLC | 441,088 | $2,735,000 | 0.60% |
| Kerrisdale Advisers, LLC | 229,347 | $1,422,000 | 0.51% |
| Worth Venture Partners, LLC | 87,908 | $545,000 | 0.30% |
| Mosaic Family Wealth, LLC | 91,314 | $566,000 | 0.24% |
| EMERALD ADVISERS, LLC | 700,176 | $4,341,000 | 0.17% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 616,664 | $3,823,000 | 0.15% |